Aysegul A Sahin

Aysegul A Sahin

UNVERIFIED PROFILE

Are you Aysegul A Sahin?   Register this Author

Register author
Aysegul A Sahin

Aysegul A Sahin

Publications by authors named "Aysegul A Sahin"

Are you Aysegul A Sahin?   Register this Author

100Publications

2409Reads

45Profile Views

MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer.

Cancer Lett 2019 Nov 29;465:12-23. Epub 2019 Aug 29.

Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Experimental Therapeutics, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA; Cancer Biology Programs, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2019.08.016DOI Listing
November 2019

Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer.

Cancer Res 2019 Aug 25;79(16):4211-4226. Epub 2019 Jun 25.

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-3803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697620PMC
August 2019

HER2 somatic mutation analysis in breast cancer: correlation with clinicopathological features.

Hum Pathol 2019 Jul 24;92:32-38. Epub 2019 Jul 24.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2019.07.006DOI Listing
July 2019

Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery.

Ann Surg Oncol 2019 Jun 14;26(6):1720-1728. Epub 2019 Mar 14.

Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-019-07226-wDOI Listing
June 2019

The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer.

J Cancer 2019 2;10(12):2635-2642. Epub 2019 Jun 2.

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.32453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584927PMC
June 2019

Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.

Int J Radiat Oncol Biol Phys 2018 11 19;102(3):568-577. Epub 2018 Jun 19.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.06.016DOI Listing
November 2018

Comparing breast biomarker status between routine immunohistochemistry and FISH studies and Oncotype DX testing, a study of 610 cases.

Breast J 2018 11 19;24(6):889-893. Epub 2018 Sep 19.

Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.13110DOI Listing
November 2018

Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.

Clin Breast Cancer 2018 10 14;18(5):347-352. Epub 2017 Dec 14.

Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.12.006DOI Listing
October 2018

Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.

Clin Breast Cancer 2018 08 13;18(4):276-281. Epub 2017 Oct 13.

Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2017.10.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899057PMC
August 2018

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1.

Cancer Cell 2018 02;33(2):187-201.e10

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Unit 108, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA; Graduate Institute of Biomedical Sciences and Center for Molecular Medicine, China Medical University, Taichung 404, Taiwan; Department of Biotechnology, Asia University, Taichung 413, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.01.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824730PMC
February 2018

Prior systemic treatment increased the incidence of somatic mutations in metastatic breast cancer.

Eur J Cancer 2018 01 9;89:64-71. Epub 2017 Dec 9.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.11.015DOI Listing
January 2018

African American patients with breast cancer have worse prognosis than white patients in certain subtypes and stages.

Breast Cancer Res Treat 2017 Dec 30;166(3):743-755. Epub 2017 Aug 30.

Department of Pathology and Laboratory Medicine, Emory University, 1364 Clifton Road, Suite H175, Atlanta, GA, 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4484-1DOI Listing
December 2017

Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells.

Mol Ther Oncolytics 2017 Sep 17;6:1-9. Epub 2017 May 17.

The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omto.2017.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458115PMC
September 2017

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy.

Br J Cancer 2017 Feb 12;116(4):509-514. Epub 2017 Jan 12.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318977PMC
February 2017

Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.

Breast Cancer Res Treat 2017 01 25;161(2):279-287. Epub 2016 Nov 25.

Department of Hematology and Medical Oncology, Glenn Family Breast Center, Winship Cancer Institute, Emory University, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4059-6DOI Listing
January 2017

Deubiquitination and Stabilization of PD-L1 by CSN5.

Cancer Cell 2016 Dec 17;30(6):925-939. Epub 2016 Nov 17.

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Unit 108, 1515 Holcombe Boulevard, Houston, TX 77030, USA; Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX 77030, USA; Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University, Taichung 404, Taiwan; Department of Biotechnology, Asia University, Taichung 413, Taiwan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.10.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5171205PMC
December 2016

Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.

Am J Pathol 2016 07 13;186(7):1900-1912. Epub 2016 May 13.

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2016.02.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929404PMC
July 2016

Biobanking in genomic medicine.

Arch Pathol Lab Med 2015 Jun;139(6):812-8

From the Departments of Pathology (Drs Zhou and Sahin) and Head and Neck Surgery (Dr Myers), University of Texas MD Anderson Cancer Center, Houston. Dr Zhou is now with Human Genome Sequencing Center, Baylor College of Medicine, Houston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2014-0261-RADOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852858PMC
June 2015

Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis.

Oncologist 2015 May 23;20(5):466-73. Epub 2015 Mar 23.

Departments of Pathology, Biostatistics, Neurosurgery, and Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425375PMC
May 2015

Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.

J Clin Oncol 2015 Apr 8;33(10):1119-27. Epub 2014 Dec 8.

Elizabeth A. Mittendorf, Min Yi, Aysegul A. Sahin, Isabelle Bedrosian, and Kelly K. Hunt, The University of Texas MD Anderson Cancer Center, Houston; Thelma Hurd, The University of Texas at San Antonio, San Antonio, TX; Karla V. Ballman, Mayo Clinic, Rochester, MN; Linda M. McCall, Duke University, Durham, NC; Nora Hansen, Northwestern University, Chicago, IL; Sheryl Gabram, Emory University, Atlanta, GA; Armando E. Giuliano, Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/10/1119.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.2958
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.2958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372850PMC
April 2015

SU2C phase Ib study of paclitaxel and MK-2206 in advanced solid tumors and metastatic breast cancer.

J Natl Cancer Inst 2015 Mar 16;107(3). Epub 2015 Feb 16.

Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/dju493DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342675PMC
March 2015

Breast pathology second review identifies clinically significant discrepancies in over 10% of patients.

J Surg Oncol 2015 Feb 1;111(2):192-7. Epub 2014 Oct 1.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.23788DOI Listing
February 2015

14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2.

Cancer Cell 2015 Feb;27(2):177-92

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2014.11.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325275PMC
February 2015

Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer.

Cancer Res 2014 Sep 26;74(17):4822-35. Epub 2014 Jun 26.

Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas. Graduate Institute for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung, Taiwan. Department of Biotechnology, Asia University, Taichung, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-0584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154991PMC
September 2014

Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study.

Hum Pathol 2014 Jul 27;45(7):1529-40. Epub 2014 Mar 27.

The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00468177140012
Publisher Site
http://dx.doi.org/10.1016/j.humpath.2014.03.006DOI Listing
July 2014

Too much, too little, or just right? Tumor margins in women undergoing breast-conserving surgery.

J Clin Oncol 2014 May 31;32(14):1401-6. Epub 2014 Mar 31.

The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.8388DOI Listing
May 2014

DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transition.

Cancer Discov 2013 Oct 9;3(10):1172-89. Epub 2013 Jul 9.

Departments of 1Genetics and, 2Hematopathology, 3Pathology,4Translational Molecular Pathology, and 5Epidemiology, The University of Texas MD Anderson Cancer Center; 6The Human and Molecular Genetics Program, The University of Texas, Graduate School of Biomedical Science at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-12-0499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107927PMC
October 2013

SRC family kinases as novel therapeutic targets to treat breast cancer brain metastases.

Cancer Res 2013 Sep 1;73(18):5764-74. Epub 2013 Aug 1.

Authors' Affiliations: Departments of Molecular and Cellular Oncology, Neurosurgery, and Pathology, The University of Texas MD Anderson Cancer Center; Cancer Biology Program, Graduate School of Biomedical Sciences-Houston, Houston, Texas; Women's Cancers Section, Laboratory of Molecular Pharmacology, National Cancer Institute, Bethesda, Maryland; and Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-1803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781592PMC
September 2013

Genetic variants in the vitamin D pathway and breast cancer disease-free survival.

Carcinogenesis 2013 Mar 24;34(3):587-94. Epub 2012 Nov 24.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs369DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581599PMC
March 2013

Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.

J Clin Invest 2012 Jun 15;122(6):2066-78. Epub 2012 May 15.

Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://www.jci.org/articles/view/59735
Publisher Site
http://dx.doi.org/10.1172/JCI59735DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3591166PMC
June 2012

Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.

Cancer 2012 Mar 25;118(6):1507-14. Epub 2011 Aug 25.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.26458DOI Listing
March 2012

PTEN, PIK3CA, p-AKT, and p-p70S6K status: association with trastuzumab response and survival in patients with HER2-positive metastatic breast cancer.

Am J Pathol 2010 Oct 2;177(4):1647-56. Epub 2010 Sep 2.

Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2010.090885DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947262PMC
October 2010

Metastasis-associated protein 1 short form stimulates Wnt1 pathway in mammary epithelial and cancer cells.

Cancer Res 2010 Aug;70(16):6598-608

Department of Biochemistry and Molecular Biology, The George Washington University Medical Center, Washington, District of Columbia 20037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-0907DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617568PMC
August 2010

Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy.

Cancer Invest 2010 Jun;28(5):554-9

Departments of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357900903286925DOI Listing
June 2010

Identification of a novel estrogen receptor-alpha variant and its upstream splicing regulator.

Mol Endocrinol 2010 May 19;24(5):914-22. Epub 2010 Mar 19.

Department of Biochemistry and Molecular Biology and Institute of Coregulator Biology, The George Washington University Medical Center, Washington, D.C. 20037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/me.2009-0413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2870933PMC
May 2010

Mucinous Lesions of the Breast.

Surg Pathol Clin 2009 Jun 2;2(2):413-40. Epub 2009 Jun 2.

Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Unit 085, Houston, TX 77030-4009, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2009.02.011DOI Listing
June 2009

Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer.

Arch Pathol Lab Med 2009 Jun;133(6):869-78

Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1043/1543-2165-133.6.869DOI Listing
June 2009

Staging of breast cancer in the neoadjuvant setting.

Cancer Res 2008 Aug;68(16):6477-81

Department of Surgery, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441792PMC
August 2008

IGFBP2 and IGFBP5 overexpression correlates with the lymph node metastasis in T1 breast carcinomas.

Breast J 2008 May-Jun;14(3):261-7. Epub 2008 Mar 27.

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2008.00572.xDOI Listing
June 2008

Correlation between CpG methylation profiles and hormone receptor status in breast cancers.

Breast Cancer Res 2007 ;9(4):R57

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1762DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206733PMC
March 2008

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.

J Clin Oncol 2008 Jan 3;26(2):246-52. Epub 2007 Dec 3.

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.5352DOI Listing
January 2008

Relationship between epidemiologic risk factors and breast cancer recurrence.

J Clin Oncol 2007 Oct 4;25(28):4438-44. Epub 2007 Sep 4.

Department of Clinical Cancer Prevention, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.10.6815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559726PMC
October 2007

Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.

Ann Surg Oncol 2007 Apr 28;14(4):1458-71. Epub 2007 Jan 28.

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-006-9236-0DOI Listing
April 2007

Comparison of full-field digital mammography and screen-film mammography for detection and characterization of simulated small masses.

AJR Am J Roentgenol 2006 Dec;187(6):W576-81

Division of Diagnostic Imaging, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Unit 57, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.05.0126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1892902PMC
December 2006

LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.

Int J Cancer 2006 Jun;118(11):2703-10

Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.21650DOI Listing
June 2006

Benign breast diseases: classification, diagnosis, and management.

Oncologist 2006 May;11(5):435-49

University of Texas M. D. Anderson Cancer Center, Unit 85, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.11-5-435DOI Listing
May 2006

The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.

Clin Cancer Res 2005 Dec;11(23):8398-402

Department of Radiation Oncology, Breast Medical Oncology, Surgical Oncology, and Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-0885DOI Listing
December 2005

Functional implications of altered subcellular localization of PELP1 in breast cancer cells.

Cancer Res 2005 Sep;65(17):7724-32

Department of Molecular and Cellular Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-0614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1343458PMC
September 2005

Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.

Mol Cancer 2005 Sep 9;4:33. Epub 2005 Sep 9.

Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-4-33DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1224867PMC
September 2005

CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation.

Cancer Res 2005 Aug;65(15):6493-7

Department of Cancer Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-1303DOI Listing
August 2005

Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets.

Hum Pathol 2005 Jun;36(6):670-5

Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2005.03.016DOI Listing
June 2005